| |
| |
|
| Insider
Information: |
Smith Jeffrey Edward |
| Relationship: |
VP of Corporate Develo... |
| City: |
Westfield |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
734,388 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,006,112 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
734,388 |
|
|
| Total
Value |
$1,006,112 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Interpace Biosciences Inc |
IDXG |
VP of Corporate Develo... |
2014-11-07 |
734,388 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IDXG |
Interpace Biosciences Inc |
VP of Corporate Development |
• – – |
2014-11-07 |
4 |
B |
$1.50 |
$349,950 |
D/D |
200,000 |
467,194 |
2.74 |
- |
|
| IDXG |
Interpace Biosciences Inc |
CFO |
• – – |
2014-02-25 |
4 |
A |
$5.13 |
$183,413 |
D/D |
35,753 |
267,194 |
0 |
- |
|
| IDXG |
Interpace Biosciences Inc |
CFO |
• – – |
2013-04-04 |
4 |
A |
$5.44 |
$139,590 |
D/D |
25,660 |
231,441 |
0 |
- |
|
| IDXG |
Interpace Biosciences Inc |
CFO |
• – – |
2013-03-01 |
4 |
D |
$7.43 |
$54,313 |
D/D |
(7,310) |
205,781 |
0 |
- |
|
| IDXG |
Interpace Biosciences Inc |
CFO |
• – – |
2012-01-30 |
4 |
A |
$6.63 |
$149,997 |
D/D |
22,624 |
219,458 |
0 |
- |
|
| IDXG |
Interpace Biosciences Inc |
CFO |
• – – |
2011-03-03 |
4 |
A |
$8.44 |
$349,998 |
D/D |
41,469 |
196,834 |
0 |
- |
|
| IDXG |
Interpace Biosciences Inc |
CFO |
• – – |
2010-12-21 |
4 |
A |
$10.98 |
$50,003 |
D/D |
4,554 |
155,365 |
0 |
- |
|
| IDXG |
Interpace Biosciences Inc |
CFO |
• – – |
2010-03-01 |
4 |
A |
$5.03 |
$95,002 |
D/D |
18,887 |
150,811 |
0 |
- |
|
| IDXG |
Interpace Biosciences Inc |
CFO |
• – – |
2009-08-21 |
4 |
B |
$5.25 |
$13,125 |
D/D |
2,500 |
131,924 |
2.74 |
- |
|
| IDXG |
Interpace Biosciences Inc |
CFO |
• – – |
2009-02-19 |
4 |
A |
$5.89 |
$105,001 |
D/D |
17,827 |
129,424 |
0 |
- |
|
| IDXG |
Interpace Biosciences Inc |
CFO |
• – – |
2008-12-02 |
4 |
B |
$4.00 |
$200,000 |
D/D |
50,000 |
111,597 |
2.74 |
- |
|
| IDXG |
Interpace Biosciences Inc |
CFO |
• – – |
2008-11-18 |
4 |
A |
$4.28 |
$100,002 |
D/D |
23,365 |
61,597 |
0 |
- |
|
| IDXG |
Interpace Biosciences Inc |
CEO |
• – – |
2008-06-26 |
4 |
B |
$8.26 |
$50,006 |
D/D |
6,054 |
38,232 |
2.74 |
- |
|
| IDXG |
Interpace Biosciences Inc |
CFO |
• – – |
2008-05-30 |
4/A |
A |
$0.00 |
$0 |
D/D |
7,424 |
32,178 |
0 |
- |
|
| IDXG |
Interpace Biosciences Inc |
CFO |
• – – |
2008-02-27 |
4 |
A |
$7.73 |
$100,003 |
D/D |
12,937 |
32,178 |
0 |
- |
|
| IDXG |
Interpace Biosciences Inc |
CFO |
• – – |
2007-03-30 |
4 |
A |
$9.52 |
$112,498 |
D/D |
11,817 |
19,241 |
0 |
- |
|
| IDXG |
Interpace Biosciences Inc |
Chief Finl Officer/TreasurerO |
• – – |
2006-05-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,424 |
|
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
